Fibrin Sealant is one of 47 small molecule programs targeting Melanoma. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
177 competitors in Melanoma
Keytruda
Opdivo
Cotellic
Zelboraf
Temodar
Taxol
Mektovi
Proleukin
Lenvima
Libtayo
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details